Capsugel is to showcase its drug delivery technologies, including the Licaps drug delivery system and Vcaps Plus capsules, at the ICSE-CPHI 2009 show in Madrid.
With a focus on helping customers meet aggressive timelines for new product development, visitors will learn how the Licaps drug delivery system enables a simple and sensible approach throughout the entire drug development process.
Capsugel will also present novel applications of its liquid-filled capsule technology, including 'capsule-in-capsule' systems that combine solid and liquid formulations to achieve specific pharmacokinetic profiles for existing or new products.
This system can simplify the process for developing combination products, such as adding vitamins and minerals to current formulations.
Capsugel will also showcase Vcaps Plus capsules, the company's newest generation of hypromellose-based two-piece capsules.
This capsule offers immediate release of API, and provides pH-independent dissolution.
It is well suited for hygroscopic formulations, as well as formulations that include materials that are moisture sensitive or chemically unstable.
Additionally, Vcaps Plus capsules are suitable for patients that prefer vegetarian capsules for ethical or cultural reasons.
Vcaps Plus capsules have been developed using Capsugel's capsule design expertise.
They meet the acceptance criteria of global regulatory authorities and are supported by international approval documentation.
This means they are ideal for manufacturing high-quality pharmaceutical products, which can be exported and marketed globally.
